X-17728157-G-A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001291867.2(NHS):c.4051G>A(p.Asp1351Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000131 in 1,209,941 control chromosomes in the GnomAD database, including 2 homozygotes. There are 40 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001291867.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NHS | NM_001291867.2 | c.4051G>A | p.Asp1351Asn | missense_variant | 7/9 | ENST00000676302.1 | NP_001278796.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NHS | ENST00000676302.1 | c.4051G>A | p.Asp1351Asn | missense_variant | 7/9 | NM_001291867.2 | ENSP00000502262.1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 22AN: 111796Hom.: 0 Cov.: 23 AF XY: 0.000265 AC XY: 9AN XY: 33974
GnomAD3 exomes AF: 0.000496 AC: 91AN: 183355Hom.: 1 AF XY: 0.000295 AC XY: 20AN XY: 67805
GnomAD4 exome AF: 0.000125 AC: 137AN: 1098145Hom.: 2 Cov.: 32 AF XY: 0.0000853 AC XY: 31AN XY: 363499
GnomAD4 genome AF: 0.000197 AC: 22AN: 111796Hom.: 0 Cov.: 23 AF XY: 0.000265 AC XY: 9AN XY: 33974
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 17, 2015 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 28, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Nance-Horan syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
NHS-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 26, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at